Colon Fibroblasts and Inflammation: Sparring Partners in Colorectal Cancer Initiation?

Colorectal cancer (CRC) is the third most common cause of cancer-related death. Significant improvements in CRC treatment have been made for the last 20 years, on one hand thanks to a better detection, allowing surgical resection of the incriminated area, and on the other hand, thanks to a better kn...

Full description

Bibliographic Details
Main Authors: Lauriane Onfroy-Roy, Dimitri Hamel, Laurent Malaquin, Audrey Ferrand
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/13/8/1749
_version_ 1797538606103920640
author Lauriane Onfroy-Roy
Dimitri Hamel
Laurent Malaquin
Audrey Ferrand
author_facet Lauriane Onfroy-Roy
Dimitri Hamel
Laurent Malaquin
Audrey Ferrand
author_sort Lauriane Onfroy-Roy
collection DOAJ
description Colorectal cancer (CRC) is the third most common cause of cancer-related death. Significant improvements in CRC treatment have been made for the last 20 years, on one hand thanks to a better detection, allowing surgical resection of the incriminated area, and on the other hand, thanks to a better knowledge of CRC’s development allowing the improvement of drug strategies. Despite this crucial progress, CRC remains a public health issue. The current model for CRC initiation and progression is based on accumulation of sequential known genetic mutations in the colon epithelial cells’ genome leading to a loss of control over proliferation and survival. However, increasing evidence reveals that CRC initiation is more complex. Indeed, chronic inflammatory contexts, such as inflammatory bowel diseases, have been shown to increase the risk for CRC development in mice and humans. In this manuscript, we review whether colon fibroblasts can go from the main regulators of the ISC homeostasis, regulating not only the renewal process but also the epithelial cells’ differentiation occurring along the colon crypt, to the main player in the initiation of the colorectal cancer process due to chronic inflammation.
first_indexed 2024-03-10T12:33:48Z
format Article
id doaj.art-5c2dbbf1e1e3448db1e22caa37054349
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-10T12:33:48Z
publishDate 2021-04-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-5c2dbbf1e1e3448db1e22caa370543492023-11-21T14:27:03ZengMDPI AGCancers2072-66942021-04-01138174910.3390/cancers13081749Colon Fibroblasts and Inflammation: Sparring Partners in Colorectal Cancer Initiation?Lauriane Onfroy-Roy0Dimitri Hamel1Laurent Malaquin2Audrey Ferrand3IRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, 31024 Toulouse, FranceIRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, 31024 Toulouse, FranceLAAS-CNRS, Université de Toulouse, CNRS, 31024 Toulouse, FranceIRSD, Université de Toulouse, INSERM, INRA, ENVT, UPS, 31024 Toulouse, FranceColorectal cancer (CRC) is the third most common cause of cancer-related death. Significant improvements in CRC treatment have been made for the last 20 years, on one hand thanks to a better detection, allowing surgical resection of the incriminated area, and on the other hand, thanks to a better knowledge of CRC’s development allowing the improvement of drug strategies. Despite this crucial progress, CRC remains a public health issue. The current model for CRC initiation and progression is based on accumulation of sequential known genetic mutations in the colon epithelial cells’ genome leading to a loss of control over proliferation and survival. However, increasing evidence reveals that CRC initiation is more complex. Indeed, chronic inflammatory contexts, such as inflammatory bowel diseases, have been shown to increase the risk for CRC development in mice and humans. In this manuscript, we review whether colon fibroblasts can go from the main regulators of the ISC homeostasis, regulating not only the renewal process but also the epithelial cells’ differentiation occurring along the colon crypt, to the main player in the initiation of the colorectal cancer process due to chronic inflammation.https://www.mdpi.com/2072-6694/13/8/1749colonfibroblastsstromacolorectal cancerinflammationintestinal stem cells
spellingShingle Lauriane Onfroy-Roy
Dimitri Hamel
Laurent Malaquin
Audrey Ferrand
Colon Fibroblasts and Inflammation: Sparring Partners in Colorectal Cancer Initiation?
Cancers
colon
fibroblasts
stroma
colorectal cancer
inflammation
intestinal stem cells
title Colon Fibroblasts and Inflammation: Sparring Partners in Colorectal Cancer Initiation?
title_full Colon Fibroblasts and Inflammation: Sparring Partners in Colorectal Cancer Initiation?
title_fullStr Colon Fibroblasts and Inflammation: Sparring Partners in Colorectal Cancer Initiation?
title_full_unstemmed Colon Fibroblasts and Inflammation: Sparring Partners in Colorectal Cancer Initiation?
title_short Colon Fibroblasts and Inflammation: Sparring Partners in Colorectal Cancer Initiation?
title_sort colon fibroblasts and inflammation sparring partners in colorectal cancer initiation
topic colon
fibroblasts
stroma
colorectal cancer
inflammation
intestinal stem cells
url https://www.mdpi.com/2072-6694/13/8/1749
work_keys_str_mv AT laurianeonfroyroy colonfibroblastsandinflammationsparringpartnersincolorectalcancerinitiation
AT dimitrihamel colonfibroblastsandinflammationsparringpartnersincolorectalcancerinitiation
AT laurentmalaquin colonfibroblastsandinflammationsparringpartnersincolorectalcancerinitiation
AT audreyferrand colonfibroblastsandinflammationsparringpartnersincolorectalcancerinitiation